Nonnucleoside reverse transcriptase inhibitors

Drugs of the Future

Volumn 25, Issue 1, 2000, Pages 47-62

  Hajós, György ^a   Riedl, Zsuzsanna ^a   Molnár, József ^b   Szabó, Diana ^b  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(2 HYDROXYETHOXY)METHYL] 6 (PHENYLTHIO)THYMINE; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BENZOTHIAZEPINE DERIVATIVE; EFAVIRENZ; ELLIPTICINE DERIVATIVE; NEVIRAPINE; NUCLEOSIDE; PROTEINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRIDONE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRIMIDINONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SULFONE DERIVATIVE; TALVIRALINE; THIOUREA DERIVATIVE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CHEMICAL REACTION; DRUG CLASSIFICATION; DRUG SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; RETROVIRUS; REVIEW;

EID: 0034100184     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2000.025.01.858638     Document Type: Review

References (72)

1. Sandström, E. Antiviral therapy in human immunodeficiency virus infection. Drugs 1989, 38: 417-50.
2. De Clercq, E. What can be expected from non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the treatment of human immunodeficiency virus type 1 (HIV-1) infections? Rev Med Virol 1996, 6: 97-117.
3. Bahar, I., Erman, B., Jernigan, R.L., Atilgan, A.R., Covell, D.G. Collective motions in HIV-1 reverse transcriptase: Examination of flexibility and enzyme function. J Mol Biol 1999, 285: 1023-37.
4. Balani, S.K., Kauffman, L.R., deLuna, F.A., Lin, J.H. Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys. Drug Metab Dispos 1999, 27: 41-5.
5. Vig, R., Mao, C., Venkatachalam, T.K., Tuel-Ahlgren, L., Sudbeck, E.A., Uckun, F.M. 5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series. Bioorg Med Chem Lett 1998, 8: 1461-6.
6. Mao, C., Vig, R., Venkatachalam, T.K., Sudbeck, E.A., Uckun, F.M. Structure-based design of N-[2-(1-piperidinylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 1998, 8: 2213-8.
7. Hsiou, Y., Das, K., Ding, J. et al. Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: Inhibitor flexibility is a useful design feature for reducing drug resistance. J Mol Biol 1998, 284: 313-23.
8. Artico, M. Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): A chemical survey from lead compounds to selected drugs for clinical trials. Il Farmaco 1996, 51: 305-31.
9. De Clercq, E. Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Exp Opin Invest Drugs 1994, 3: 253-71.
10. Miyasaka, T., Tanaka, H., Baba, M. et al. A novel lead for specific anti-HIV-1 agents: 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine. J Med Chem 1989, 32: 2507-9.
11. Tanaka, H., Baba, M., Hayakawa, H. et al. A new class of HIV-1-specific 6-substituted acyclouridine derivatives: Synthesis and anti-HIV-1 activity of 5-or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J Med Chem 1991, 34: 349-57.
12. Tanaka, H., Baba, M., Saito, S. et al. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: Synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J Med Chem 1991, 34: 1508-11.
13. Tanaka, H., Baba, M., Ubasawa, M. et al. Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogues of 1-1(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). J Med Chem 1991, 34: 1394-9.
14. Tanaka, H., Takashima, H., Ubasawa, M. et al. Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine analogues: Effect of substitutions at the C-6 phenyl ring and at the C-5 position of anti-HIV-1 activity. J Med Chem 1992, 35: 337-45.
15. Tanaka, H., Takashima, H., Ubasawa, M. et al. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. J Med Chem 1992, 35: 4713-9.
16. Balzarini, J., Pérez-Pérez, M-J., San-Félix, A., Vélazquez, S., Camarasa, M-J., De Clerq, E. [2′,5′-Bis-O-(tert-butyldimethylsilyl)]-3′-spiro-5″- (4″-amino-1″,2″-oxathiole-2″,2″-dioxide) (TSAO) derivatives of purine and pyrimidine nucleosides as potent and selective inhibitors of human immunodeficiency virus type 1. Antimicrob Agents Chemother 1992, 36: 1073-80.
17. Tramontane, E., Marongiu, M.E., De Montis, A. et al. Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors. Microbiologica 1994, 17: 269-79.
18. Mai, A., Artico, M., Sbardella, G. et al. Preparation and anti-HIV-1 activity of 6-benzyl-2-alkylthio-3,4-dihydro-(5-alkyl)-4-oxopyrimidines and related compounds. J Med Chem 1995, 38: 3258-63.
19. De Clercq, E. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance development. Med Res Rev 1996, 16: 125-57.
20. Dollé, V., Fan, E., Nguyen, C.H. et al. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors. J Med Chem 1995, 38: 4679-86.
21. Nguyen, C.H., Bisagni, E.A. General route to 5- and 6-substituted 4-amino-2-oxo-1,2-dihydropyridines. Synthesis 1984, 765-6.
22. Brichter, S.F., Goldman, M.E., Huff, J.R. et al. Quinazoline derivatives as inhibitors of HIV reverse transcriptase. EP 530994.
23. Tucker, T.J., Lyle, T.A., Wiscount, C.M. et al. Synthesis of a series of 4-(arylethynyl)-6-chloro-4-cyclopropyl-3,4-dihydroquinazolin-2(1H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. J Med Chem 1994, 37: 2437-44.
24. Buckheit, R.W. Jr., Fliakas-Boltz, V., Decker, W.D. et al. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Res 1994, 25: 43-56.
25. Chimirri, A., Grasso, S., Monforte, A.M., Monforte, P., Zappala, M. Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. Farmaco 1991, 46: 925-33.
26. Chimirri, A., Grasso, S., Monforte, A.M., Monforte, P., Zappala, M., Carotti, A. Structure-activity relationships of antitumor thiazolo[3,4-a]benzimidazole derivatives. Farmaco 1994, 49: 337-44.
27. Artico, M., Silverstri, R., Pagnozzi, E. et al. 5H-Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A novel class of non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem 1996, 4: 837-50.
28. Chimirri, A., Grasso, S., Monforte, A.M., Monforte, P., Zappala, M. Anti-HIV agents III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines. Farmaco 1994, 49: 345-8.
29. Mertens, A., Zilch, H., König, B. et al. Selective non-nucleoside HIV-1 reverse transcriptase inhibitors. New 2,3-dihydrothiazolo[2,3-a]isoindol-5(9bH)-ones and related compounds with anti-HIV-1 activity. J Med Chem 1993, 36: 2526-35.
30. Roth, T., Morningstar, M.L., Boyer, P.L., Hughes, S.H., Buckheit, R.W., Michejda, C.J. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. J Med Chem 1997, 40: 4199-207.
31. Kilby, J., Saag, M.M. Clinical experience with non-nucleoside reverse transcriptase inhibitors. Advances in experimental. Med Biol 1996, 394: 291-8.
32. Adams, J., Hargrave, K.D. Discovery and development of a non-nucleoside reverse transcripase inhibitor. Special Publication. Royal Soc Chem 1993, 119: 282-96.
33. Hargrave, K.D., Proudfoot, K.D. Jr., Grozinger, K.G. et al. Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones. J Med Chem 1991, 34: 2231-41.
34. Terrett, N.K., Bojanic, D., Merson, J.F., Stephenson, P.T. Imidazo[2′,3′:6,5]-1,4-diazepines non-nucleoside HIV-1 reverse transcriptase inhibitors with greater enzyme affinity than nevirapine. Bioorg Med Chem Lett 1992, 2: 1745-50.
35. Kelly, T.A., McNeil, D.W., Rose, J.M., David, E., Shih, C-K., Grob, P.M. Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 6. 2-Indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones. J Med Chem 1997, 40: 2430-3.
36. Klunder, J.M., Hoermann, M.A., Cywin, C.L. et al. Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes. J Med Chem 1998, 41: 2960-71.
37. Pauwels, R., Andries, K., Desmyter, J. et al. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 1990, 343: 470-4.
38. Kukla, M.J., Breslin, H.J., Pauwels, R. et al. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. J Med Chem 1991, 34: 746-51.
39. Kukla, M.J., Breslin, H.J., Diamond, C.G. et al. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2. J Med Chem 1991, 34: 3187-97.
40. Breslin, H.J., Kukla, M.J., Ludovici, D.W. et al. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 3. J Med Chem 1995, 38: 771-93.
41. Ho, W., Kukla, M.J., Breslin, H.J. et al. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 4. J Med Chem 1995, 38: 794-802.
42. Campiani, G., Nacci, V., Fiorini, I. et al. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: Novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity. J Med Chem 1996, 39: 2672-80.
43. Romero, D.L., Morge, R.A., Biles, C. et al. Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors. J Med Chem 1994, 37: 999-1014.
44. Romero, D.L., Morge, R.A., Genin, M.J. et al. Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: Structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3-[(1-methylethyl(amino]- pyridinyl]piperazine monomethanesulfonate (U-80152S), a second-generation clinical candidate. J Med Chem 1993, 36: 1505-8.
45. Pauwels, R., Andries, K., Debyser, Z. et al. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of a-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. Proc Natl Acad Sci USA 1993, 90: 1711-5.
46. Bell, F.W., Cantrell, A.S., Hogberg, M. et al. Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs. J Med Chem 1995, 38: 4929-36.
47. Ahgren, C., Backro, K., Bell, F.W. et al. The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 1995, 39: 1329-35.
48. Balzarini, J. et al. Thiocarboxamide derivatives: Highly potent and selective HIV inhibitors with a broad activity spectrum against mutant HIV-1 strains resistant to other non-nucleoside reverse transcriptase inhibitors. 11th Int Conf AIDS (July 7-12, Vancouver) 1996, Abst Mo.A.1051.
49. Golebiewski, W.M. et al. Design and synthesis of cosalane, a novel anti-HIV agent. Bioorg Med Chem Lett 1993, 3: 1739.
50. Cushman, M., Golebiewski, W.M., Graham, L. et al. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. J Med Chem 1996, 39: 3217-27.
51. Cushman, M., Golebiewski, W.M., McMahon, J.B. et al. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem 1994, 37: 3040-50.
52. Cushman, M., Casimiro-Garcia, A., Hejchman, E. et al. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors. J Med Chem 1998, 41: 2076-89.
53. Wishka, D.G., Graber, D.R., Kopta, L.A. et al. (-)-6-Chloro-2-[(1-furo[2,3-c]pyridin-5-yl-ethyl)thio]-4-pyridinamine PNU-142721, a new broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitor. J Med Chem 1998, 41: 1357-60.
54. McMahon, J.B., Gulakowski, R.J., Weislow, O.S. et al. Diarylsulfones, a new class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 1993, 37: 754.
55. Williams, T.M., Ciccarone, T.M., Mactough, S.C. et al. 5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: A novel non-nucleoside inhibitor of HIV-1 reverse transcriptase. J Med Chem 1993, 36: 1291-4.
56. Young, S.D., Amblard, M.C., Britcher, S.F. et al. 2-Heterocyclic indole-3-sulfones as inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett 1995, 5: 491-6.
57. Artico, M., Silvestri, R., Stefancich, G. et al. Synthesis of pyrrolylaryl sulfones targeted at the HIV-1 reverse transcriptase. Arch Pharm (Weinheim) 1995, 328: 223-9.
58. Timári, G., Soós, T., Hajós, Gy., Messmer, A., Nacsa, J., Molnár, J. Synthesis of novel ellipticine analogues and their inhibition of Moloney leukemia reverse transcriptase. Bioorg Med Chem Lett 1996, 6: 2831-6.
59. Kleim, J-P., Bender, R., Billhardt, U-M. Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication. Antimicrob Agents Chemother 1993, 37: 1659-64.
60. Kleim, J-P., Bender, R., Kirsch, R. Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother 1995, 39: 2253-7.
61. Antonucci, T., Warmus, J.S., Hodges, U.C., Nickell, D.G. Characterization of the antiviral activity of highly substituted pyrroles: A novel class of non-nucleoside HIV-1 reverse transcriptase inhbitor. Antiviral Chem Chemother 1995, 6: 98.
62. Livermore, D.G.H., Bethell, R.C., Cammack, N. et al. Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines. J Med Chem 1993, 36: 3784.
63. Nakane, H., Ono, K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry 1990, 29: 2841-5.
64. Nakane, H., Arisawa, M., Fujita, A., Koshimura, S., Ono, K. Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. FEBS Lett 1991, 286: 83-5.
65. Tan, G.T., Kinghorn, A.D., Hughes, S.H., Pezzuto, J.M. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. J Biol Chem 1991, 226: 23529-36.
66. Temin, H.M., Mizutani, S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970, 226: 1211-3.
67. Weiss, R.A. HIV receptors and the pathogenesis of AIDS. Science 1996, 212: 1885-6.
68. Barré-Sinoussi, F., Chermann, J.C., Rey, F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983, 220: 868-71.
69. Clavel, F., Guetard, D., Brun-Vezinet, F. et al. Isolation of a new human retrovirus from a West Africa patient with AIDS. Science 1986, 233: 343-6.
70. Esnouf, R., Ren, J., Ross, C., Jones, Y., Stammers, D., Stuart, D. Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nat Struct Biol 1995, 2: 303-8.
71. Hewlett, I., Lee, S., Molnár, J. et al. Inhibition of HIV infection of H9 cells by chlorpromazine derivatives. J Acquir Immune Defic Syndr Hum Retrovir 1997, 15: 16-20.
72. Kidd, S.E., Nelson, M.J., Epstein, M., Aszalós, A., Pine, S., Molnár, J. Inhibition of GP 120 and antibodies binding to CD4 by metal complexes. Anti-infect Drugs Chemother 1997, 15: 71-7.